Skip to main content

Coronavirus (COVID-19): Latest Updates | Visitation PoliciesVisitation PoliciesVisitation PoliciesVisitation PoliciesVisitation Policies | COVID-19 Testing | Vaccine InformationVaccine InformationVaccine Information

menu

Department of Medicine

Infectious Diseases

URMC / Medicine / Infectious Diseases / Research / HIV/AIDS Clinical Trials Unit / UR Adult HIV Therapeutic Strategies Clinical Research

UR Adult HIV Therapeutic Strategies Clinical Research

Virus (in blue) in bloodThe University of Rochester (UR) AIDS Clinical Trials Unit (ACTU) Clinical Research Site (CRS) was one of the first 10 sites funded by the National Institutes of Health (NIH) in 1986.  Since that time, the unit has enrolled over 1800 participants in more than 50 studies.

The University of Rochester ACTU is a part of a large NIH cooperative group known as the AIDS Clinical Trials Group (ACTG), dedicated to research trials in HIV and AIDS.  The unit’s research team includes specialized research nurses, doctors, and support staff committed to providing excellent care.  The staff works with research patients and primary care physicians to coordinate the HIV care of each patient.  They remain committed to generate high quality research.

Patients usually participate in trials on an outpatient basis.  They continue to receive treatment for non-study related diagnoses from their own primary care provider.